Hilary Tindle, MD, MPH, associate professor of medicine, Vanderbilt University, spoke about the use of precision medicine approaches, such as the nicotine metabolite ratio (NMR), to improve outcomes for patients with lung cancer.
Hilary Tinde, MD, MPH, associate professor of medicine at Vanderbilt University spoke about previous trials using the nicotine metabolite ratio (NMR) and precision medicine approaches to improve outcomes in patients with lung cancer.
What are some effective treatments for quitting smoking and why are they being underutilized? How can precision approaches improve treatment?
Precision approaches stand to improve treatment in a variety of ways. But first, I can give you a sense of what's available for treating smoking. The most important things to do when a patient wants to quit smoking is to combine counseling, behavioral techniques like from a quit line, or a health care provider, and FDA-approved medication. And the FDA-approved medications are things like nicotine replacement, like the patch, gum, or lozenge; those are available over the counter.
And there are also prescription medications such as arenicline, which is also known as Chantix, that a doctor or prescribing health care provider can write a prescription for, and a patient can go pick that up at the pharmacy.
Combining these 2 things, counseling and medication, is the best way to quit smoking because it grandly, greatly increases chances of quitting for good, as opposed to when people don't use these quit aids, these proven aids, about 95 out of 100 quit attempts fail.
When you think about the bigger picture, there are about 30 million Americans now who smoke cigarettes, American adults. And over half are trying to quit every year. But only 5% of those individuals, so over 15 million people trying to quit, only about 5% use counseling and medication. And that's why most people keep smoking and are unsuccessful in quitting. There are lots of reasons you might ask why are these proven aids, these proven medications not used. And a lot of it has to do with historical context. In the past our nation, just our health care system, didn't necessarily think of smoking as a chronic disease that needed, like diabetes, to be treated with behavioral intervention, such as counseling plus medication.
We know better now, but it takes a while to undo some of those myths. Patients might not think that they need meds, and their health care providers might or might not think that they need to provide them. But precision medicine and precision approaches can really improve things, potentially. And that's one reason I'm so excited about using them and developing them, because patients have something to be excited about when we can tailor a medication to a patient's genetics.
For example, we can boost the efficacy or the effectiveness of that medication, and even double quit rates. So that's one example. That might make health care providers more excited to or enthusiastic to prescribe those medications. Those are just a couple examples of how precision approaches could help.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More